Skip to main content
AlzChem Group AG logo

AlzChem Group AG — Investor Relations & Filings

Ticker · ACT ISIN · DE000A2YNT30 LEI · 8945004EL7WZK3ERG181 F Manufacturing
Open in API
Filings indexed 414 across all filing types
Latest filing 2021-06-09 Regulatory Filings
Country DE Germany
Listing F ACT

About AlzChem Group AG

https://www.alzchem.com/en

AlzChem Group AG is a globally active, vertically integrated specialty chemicals company focused on NCN (Nitrogen-Carbon-Nitrogen) chemistry. Its production chain is based on raw materials such as calcium carbide and calcium cyanamide, from which it develops a wide range of products. The company serves diverse markets including human and animal nutrition, pharmaceuticals, agriculture, metallurgy, renewable energy, and automotive. Key products include high-purity creatine for dietary supplements (Creapure®), feed additives for animal nutrition (Creamino®), and high-purity guanidine salts used as intermediates for pharmaceutical and diagnostic applications, such as PCR tests. AlzChem also offers custom synthesis services and is a market leader in many of its business segments.

Recent filings

Filing Released Lang Actions
AlzChem Group AG: Re-placement of shares successfully completed
Regulatory Filings Classification · 99% confidence The document is a short news release dated June 9, 2021, announcing the successful completion of a 'Re-placement of shares' involving major shareholders (LIVIA Corporate Development SE and HDI Vier CE GmbH) and noting the resulting increase in free float and liquidity. This transaction involves the transfer or placement of existing shares, which falls under capital structure changes or share transactions. Since the text explicitly discusses the re-placement/transfer of shares between existing large holders and the market, it aligns best with 'Share Issue/Capital Change' (SHA) or 'Transaction in Own Shares' (POS). Given that it's a notification about the completion of a placement/re-placement of existing shares by major shareholders, it is most accurately classified as a notification related to share capital changes or transactions. 'SHA' covers capital changes, and 'POS' covers transactions in own shares (though this is a placement by existing holders, not necessarily the company buying back). However, the core event is a significant change in shareholding structure and liquidity due to a placement. Comparing the definitions, 'SHA' (Share Issue/Capital Change) is a broad fit for significant ownership structure shifts resulting from placements. 'POS' (Transaction in Own Shares) usually implies the company itself is the buyer/seller. Since this is a placement by existing large shareholders, 'SHA' is a reasonable fit for a capital structure event, but 'RNS' (Regulatory Filings) is often used for general news releases disseminated via DGAP/EQS that don't fit a specific financial report type. Given the specific nature of share placement/transfer, 'SHA' is the most specific fit among the transaction types, although it is not a primary issuance. Let's re-evaluate against the options. It is not an ER, IR, 10-K, or AGM material. It is a notification about share movement. 'SHA' covers capital changes. 'POS' covers transactions in own shares. Since this is a placement of existing shares by large shareholders, it is a significant capital/ownership event. I will select SHA as the most relevant category for a major change in share distribution/capital structure, even if it's not a primary issuance by the company itself. However, because this is a short news item disseminated via DGAP announcing the completion of a transaction, and it doesn't fit perfectly into the specific financial report codes, 'RNS' (Regulatory Filings) is a strong candidate based on the 'Menu vs Meal' rule if it were just announcing a report. Since it *is* the news itself, and it concerns share movement, SHA is better. Given the context of DGAP news releases, if it's not a formal report, RNS is the fallback. But the content is clearly about share capital movement. I will stick with SHA as the content is highly specific to share structure changes.
2021-06-09 English
DGAP-DD: AlzChem Group AG english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'DGAP-DD: AlzChem Group AG english' and contains the header 'Directors’ Dealings'. Section 2 details the 'Reason for the notification' concerning a 'Person closely associated with' a member of the administrative body, and Section 4 details the 'transaction(s)' involving the disposal of shares. This content directly matches the definition for Director's Dealing reports.
2021-06-09 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Voting Rights Announcements' and contains detailed tables regarding 'Stimmrechtsmitteilung' (Voting Rights Notification) under German law (§ 40 Abs. 1 WpHG). It specifies the acquirer/disposer of voting rights (Metainvest AB), the threshold crossed, and the resulting percentage of voting rights (3.01%). This directly corresponds to the definition of a notification regarding changes in significant share ownership levels or voting rights, which aligns best with the 'Declaration of Voting Results & Voting Rights Announcements' category (DVA), although the content is specifically about voting rights changes rather than the final results of a meeting. Given the options, DVA is the most precise fit for a formal voting rights notification.
2021-06-08 German
AlzChem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 11th Interim report
Transaction in Own Shares Classification · 100% confidence The document explicitly discusses the acquisition of shares by AlzChem Group AG as part of a share buyback program, detailing the number of shares bought and the aggregated volume over several days (May 31 to June 4, 2021). This directly relates to the company repurchasing its own shares. The filing type definition for 'Transaction in Own Shares' (POS) covers 'Report of the company buying back or selling its own shares (share repurchase/issuance)'. Although the document mentions an '11th Interim report' in the header, the core content is the disclosure of the share buyback activity required under EU regulations (EU Regulation 596/2014), making POS the most accurate classification for the substance of this specific announcement.
2021-06-07 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Voting Rights Announcements' and explicitly mentions 'Veröffentlichung einer Stimmrechtsmitteilung' (Publication of a voting rights notification) under German WpHG regulations (§ 40 Abs. 1 WpHG). It details changes in share ownership thresholds (e.g., 'Erwerb bzw. Veräußerung von Aktien mit Stimmrechten') and reports the new total voting rights percentage (3.01%). This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes or, in this context, mandatory notifications regarding changes in voting power.
2021-06-04 German
AlzChem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052
Transaction in Own Shares Classification · 100% confidence The document explicitly details the acquisition of shares by AlzChem Group AG as part of a share buyback program, providing specific dates, quantities, and weighted average prices for the transactions between May 24 and May 28, 2021. This directly relates to the company managing its own stock. The filing category 'Transaction in Own Shares' (POS) is the most appropriate classification for share repurchase activities. Although it mentions an '10th Interim report' in the header, the core content is the buyback disclosure, which is a specific transaction report, not the interim financial report itself. The document length is short (3069 chars), but the content is a direct disclosure of the transaction, not just an announcement of a report's publication.
2021-05-31 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.